Mental Health Clinician Volume 2: Issue 12

Select Issue

Editorial: Elevating to new heights in neuropsychiatric pharmacy at the 2013 CPNP Annual Meeting

Pharm.D., BCPS, BCPP

Disclaimer: The editorial below does not reflect any opinion of or endorsement by the United States Government or the Department of Veterans Affairs.

The theme of this year's CPNP Annual Meeting was “Elevating to New Heights in Neuropsychiatric Pharmacy.” This editorial will explain one perspective on how attendees at the annual meeting were encouraged to pursue this goal.

First and foremost, we were encouraged to elevate our knowledge. This was done primarily through the informative continuing education (CE) sessions provided throughout the conference. While all the sessions were informative, we have chosen to highlight a few of the

Download PDF

Academic detailing: Using clinical evidence to improve care

Pharm.D, BCPP

DOI: 10.9740/mhc.n155291

Academic detailing is an educational outreach service that is effective at promoting evidence-based treatment for a given therapeutic area. This article describes what academic detailing entails, and reviews the findings of studies on the impact of academic detailing on prescribing practices.

Download PDF

Opioid induced hyperalgesia: A focus on opioid use in chronic pain

Pharm.D., BCPP

DOI: 10.9740/mhc.n155462

Opioids are a well-established treatment option for chronic pain. However, opioid therapy is associated with many side effects, including opioid induced hyperalgesia (OIH). This article reviews studies which have evaluated OIH in chronic pain patients on opioids.

Download PDF

Urea cycle disorder

Pharm.D., BCPP

DOI: 10.9740/mhc.n155467

Urea cycle disorder is a rare genetic disorder in which there is a full or partial deficiency in the enzymes of the urea cycle, causing a defect in the metabolism of excess nitrogen, and leading to hyperammonemia. This article reviews the clinical presentation, diagnosis, treatment, and drug-disease state implications of urea cycle disorders.

Download PDF

Delirium in practice today

Pharm.D., BCPP

DOI: 10.9740/mhc.n155504

Delirium occurs frequently in intensive care units (ICUs), and complicates treatment and patient outcomes. This article reviews risk factors, diagnosis, and guidelines for treatment of delirium in the ICU setting.

Download PDF

Obsessive-compulsive disorder in pediatrics and adolescents: Review of treatment and future directions

Pharm.D. and

Pharm.D., BCPS, BCPP, FASHP

DOI: 10.9740/mhc.n155509

Obsessive-compulsive disorder (OCD) is an anxiety disorder associated with significant morbidity, and found at a relatively high overall prevalence in the pediatric and adolescent population. This article reviews the treatment of OCD in pediatrics and adolescents.

Download PDF

The use of antipsychotics in maintenance treatment of bipolar disorder

Pharm.D.

DOI: 10.9740/mhc.n155513

Antipsychotics are often used in the treatment of the acute phase of bipolar disorder; however, once the acute phase has resolved and patients enter the maintenance phase, there is some debate as to whether or not to continue the antipsychotic. This article reviews studies examining the use of antipsychotics in the maintenance phase of bipolar disorder.

Download PDF

Transforming 300 billion points of data into diagnostics, therapeutics and new insights into disease

Pharm.D., BCPP

DOI: 10.9740/mhc.n155664

INTRODUCTION

Over the past few years, collaboration between the CPNP Research and Program Committees has resulted in high quality, member-driven research programming at the Annual Meeting. Programming input is requested from all CPNP committees but this collaboration, in particular, has led to the development of focused programming fulfilling a need for members who either work primarily in a research setting or want to keep abreast of the ever-changing field of psychopharmacology research. One of the logistical difficulties of this type of collaboration is the CPNP programming timeline. It is not long after the Annual Meeting that the following year's offerings

Download PDF

Book Review: Essential evidence-based psychopharmacology, 2nd edition

PharmD, BCPS, BCPP

DOI: 10.9740/mhc.n155671

CPNP members maintain a suggested reading list to provide information on peer recommended resources and convenient access to the highest quality neuropsychopharmacology publications. A reminder that if you shop with CPNP, by following the links below to Amazon, a small commission will be paid to CPNP which helps to financially support our mission to improve the minds and lives of individuals with psychiatric and/or neurologic disorders.

You can help grow this list of resources by suggesting a book.

Book: Essential Evidence-Based Psychopharmacology, 2^nd edition

From the publisher

This volume presents up-to-date, comprehensive and

Download PDF

Movie Review: Nerve

, and

DOI: 10.9740/mhc.n153897

Nerve: Josh Biggs is a silent sufferer living with social anxiety disorder (SAD). His co-worker, Aurora, recognizes this and recruits Josh to take part in her graduate thesis, titled “Social Anxiety in Dating Initiation.” She believes that she can help Josh overcome his anxiety through exposure-based therapy, and gives him the first of several assignments: receive thirty rejections in one day. Josh struggles with Aurora's tasks at first, and it is very clear that he harbors a fear of intimacy--he avoids forming relationships with other people because he believes they will label him as unworthy once they know him.

Download PDF

Reflections

DOI: 10.9740/mhc.n153888

As CPNP's fiscal year and my term as president wind down, it's impossible not to reflect on this past year's events. It has been a distinct honor and privilege to serve as president of our organization. Our engaged membership, the other volunteer leaders, and the CPNP Staff make that task seem almost easy. With the help of all of those people, CPNP has moved forward in a number of arenas during the past year. I want to take this opportunity to highlight some of the significant developments and accomplishments from the last year.

This year started with a concerted initiative

Download PDF

CPNP Announcements

DOI: 10.9740/mhc.n154950

INTERVIEW WITH INCOMING CPNP PRESIDENT JULIE DOPHEIDE

During the 2013 Annual Meeting, the Mental Health Clinician was able to spend a few minutes with the incoming president for the 2013–14 year, Julie Dopheide, Pharm.D., BCPP. Dr. Dopheide received her Doctor of Pharmacy degree from the University of Nebraska and subsequently completed a psychiatric pharmacy residency at the University of Southern California (USC) in Los Angeles (LA), California. Currently, Dr. Dopheide is an Associate Professor at USC and has faculty appointments to both the School of Pharmacy and the School of Medicine. She practices at the LA County Medical Center and

Download PDF

Editorial: Elevating to new heights in neuropsychiatric pharmacy at the 2013 CPNP Annual Meeting

Academic detailing: Using clinical evidence to improve care

Opioid induced hyperalgesia: A focus on opioid use in chronic pain

Urea cycle disorder

Delirium in practice today

Obsessive-compulsive disorder in pediatrics and adolescents: Review of treatment and future directions

The use of antipsychotics in maintenance treatment of bipolar disorder

Transforming 300 billion points of data into diagnostics, therapeutics and new insights into disease

INTRODUCTION

Book Review: Essential evidence-based psychopharmacology, 2nd edition

From the publisher

Movie Review: Nerve

Reflections

CPNP Announcements

INTERVIEW WITH INCOMING CPNP PRESIDENT JULIE DOPHEIDE

Pharmacist administration of long-acting injectable medications for substance use disorders: A scoping review

Transitions of care: Assessment of adherence to long-acting injectable antipsychotic treatment following discharge from inpatient psychiatry

Use of atypical antipsychotics in individuals with anorexia nervosa

Potential changes impacting psychiatric pharmacy by 2030

A model for timely dissemination of critical information: Clozapine toxicity during the COVID pandemic